[go: up one dir, main page]

CN113856014A - Precise dosing control system - Google Patents

Precise dosing control system Download PDF

Info

Publication number
CN113856014A
CN113856014A CN202111289039.6A CN202111289039A CN113856014A CN 113856014 A CN113856014 A CN 113856014A CN 202111289039 A CN202111289039 A CN 202111289039A CN 113856014 A CN113856014 A CN 113856014A
Authority
CN
China
Prior art keywords
drug
drug delivery
storage tank
mems
control system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111289039.6A
Other languages
Chinese (zh)
Inventor
陶智
黄毅
李海旺
于湛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beihang University
Original Assignee
Beihang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beihang University filed Critical Beihang University
Priority to CN202111289039.6A priority Critical patent/CN113856014A/en
Publication of CN113856014A publication Critical patent/CN113856014A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0662Ears

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

精准给药控制系统,涉及一种给药装置,解决现有耳蜗给药的装置存在药品消耗量大,使用效率低且无法实现精准给药等问题,本发明包括集成在外壳体的IC集成电路、MEMS微泵、储药池和储能装置;IC集成电路分别与MEMS微泵和储能装置连接,MEMS微泵的入口与储药池的出口连接;储药池还设置有入口和换气口;储能装置的电压经所述IC集成电路放大后作用于MEMS微泵,驱动微泵进行药液输入。本发明通过液滴式精确控制药液流量,能够根据所需的给药频率精确控制流量,使药液以液滴的方式持续作用于耳蜗,保证药物浓度维持在合适的范围,同时可以减少药物经咽鼓管流出的损失,增加药物的利用率,增强药物的作用效果,延长药物的有效作用时间。

Figure 202111289039

A precise drug delivery control system relates to a drug delivery device, which solves the problems of large drug consumption, low use efficiency and inability to achieve precise drug delivery in the existing cochlear drug delivery device. The invention includes an IC integrated circuit integrated in an outer casing. , MEMS micropump, medicine storage tank and energy storage device; IC integrated circuit is connected with MEMS micropump and energy storage device respectively, the inlet of MEMS micropump is connected with the outlet of medicine storage tank; medicine storage tank is also provided with inlet and ventilation port; the voltage of the energy storage device is amplified by the IC integrated circuit and then acts on the MEMS micro-pump to drive the micro-pump to input medicinal liquid. The invention precisely controls the flow rate of the medicinal liquid through the droplet type, and can precisely control the flow rate according to the required administration frequency, so that the medicinal liquid can continuously act on the cochlea in the form of droplets, so as to ensure that the drug concentration is maintained in an appropriate range, and at the same time, the drug can be reduced The loss of the outflow through the Eustachian tube increases the utilization rate of the drug, enhances the effect of the drug, and prolongs the effective action time of the drug.

Figure 202111289039

Description

Accurate control system that doses
Technical Field
The invention relates to a drug delivery device, in particular to an accurate drug delivery control system.
Background
China is the country with the most hearing disabilities worldwide, and the medical treatment demand is huge. The treatment of hearing loss is critical to the precise administration of drugs to the inner ear, especially the cochlea. In addition to the fact that the traditional drug delivery device is difficult to act on the inner ear through blood circulation, the traditional drug delivery device has the limitations of high drug bottle consumption, low efficiency, large toxic and side effects, high trauma, susceptibility to infection and the like, and the microchip has the advantages of integration, high precision, low toxic and side effects and the like.
The currently reported cochlear administration devices all have certain drawbacks. For example, the traditional drug delivery device has the defects of large drug consumption, low efficiency, large toxic and side effect, high wound, susceptibility to infection and the like. The prior art discloses a cochlea hose ware of dosing, its medicine outlet is hollow out construction, and the application mechanical principle will be stored in the liquid medicine of giving the medicine inslot and pass through the push rod and spout the cochlea affected part, and this kind of dosing device simple structure, unable accurate control liquid medicine flow, uncontrollable with the contact time of round window membrane, and because the injection causes the medicament extravagant, the liquid medicine mostly can be followed eustachian tube and run off, only has trace liquid medicine to save in round window membrane affected part. In addition, such devices do not allow for continuous administration of the drug. The earplug type tympanometry drug delivery device invented by Liwangwei and the like of Nanjing Chinese medicine university conveys the liquid medicine to the cochlea by puncturing the tympanic membrane, and has the defects of liquid medicine waste and incapability of quantitatively and accurately controlling the flow of the liquid medicine. Although the micro automatic controlled release drug can reduce toxic and side effects, the release of the drug is limited by physiological factors, and the control precision is about 1 mg/h. In order to realize local accurate drug delivery of the cochlea, the invention provides a novel drug delivery system.
Disclosure of Invention
The invention provides an accurate drug delivery control system for solving the problems that the traditional cochlear drug delivery device has high drug consumption, low use efficiency, incapability of realizing quantitative and accurate control of drug delivery and the like.
The accurate drug delivery control system comprises an IC integrated circuit, an MEMS micropump, a drug storage pool and an energy storage device which are integrated on an outer shell;
the IC integrated circuit is respectively connected with the MEMS micropump and the energy storage device, and an inlet of the MEMS micropump is connected with an outlet of the medicine storage pool;
the medicine storage pool is also provided with an inlet and a ventilation port;
the voltage of the energy storage device is amplified by the IC integrated circuit and then acts on the MEMS micropump to drive the micropump to input liquid medicine.
Further, the IC integrated circuit and the medicine storage pool are respectively positioned at the upper part and the lower part of the outer shell; the material of medicine storage tank is the PE material, and the vent of medicine storage tank adopts the ventilative design of pellicle, the pellicle material is medical grade ePTFE material.
Further, the MEMS micropump is square.
Furthermore, the energy storage device is a lithium battery, and the lithium battery is placed in the MEMS micropump.
The invention has the beneficial effects that: the accurate drug delivery control system provided by the invention can accurately control the flow of the liquid medicine in a liquid drop mode by accurately controlling the flow according to the required drug delivery frequency, so that the liquid medicine continuously acts on a cochlea in a liquid drop mode, the concentration of the drug is ensured to be maintained in a proper range, meanwhile, the loss of the drug flowing out through a eustachian tube can be reduced, the utilization rate of the drug is increased, the action effect of the drug is enhanced, and the effective action time of the drug is prolonged. And the invention can be extended to intramuscular injection type drug delivery systems.
1. The whole layout is novel, the size is small, the space utilization rate is high, the wearable type cochlear implant can be worn, and besides being applied to cochlear treatment, the cochlear implant can also be applied to intramuscular injection, and the application range is wide;
2. the accurate flow control of the micropump can achieve the micro drug delivery flow required in the treatment of the inner ear, and can accurately control the flow according to the requirement, and the flow control is simple and convenient; the invention can adopt micro-droplets and a tissue infiltration mode, can achieve the fine flow of 0.44mg/h and is not influenced by physiological factors.
3. The invention has higher practical value and can realize quantitative administration for a plurality of times by implantation once;
4. the manufacturing cost is low, and mass production can be realized.
Drawings
FIG. 1 is an assembly view of a precision drug delivery control system according to the present invention;
FIG. 2 is a schematic diagram of the overall packaging of the precise drug delivery control system according to the present invention;
fig. 3 is a graph showing the flow effect of the micro-pump under different voltages and frequencies in two operation modes (i.e. droplet mode and tissue penetrating mode).
In the figure, 1, a shell, 2, a MEMS micropump, 3, an IC integrated circuit, 4, a battery, 5 and a medicine storage pool.
Detailed Description
Referring to fig. 1 to 3, the precise drug delivery control system of the present embodiment includes a drug reservoir 5, a MEMS micro pump 2, a battery 4 (energy storage device), an IC integrated circuit 3, and a housing 1, and the assembly diagram is shown in fig. 1. The IC integrated circuit 3 is positioned on the upper part of the shell 1, one end of the IC integrated circuit is connected with the MEMS micropump 2 through a lead, the other end of the IC integrated circuit is connected with the battery 4 through a lead, the battery 4 is placed on the MEMS micropump 2, the inlet of the MEMS micropump 2 is connected with the medicine storage pool 5, and the medicine storage pool 5 is positioned at the lowest end of the shell 1.
In this embodiment, the liquid medicine is stored in the medicine storage tank, and the medicine storage tank design is similar in order to increase space utilization with casing the latter half shape, and the material in medicine storage tank adopts the nontoxic biocompatible PE material to the human body, and total volume is about 1ml, and its scavenge port adopts the ventilative design of pellicle, and the membrane material is medical grade expanded polytetrafluoroethylene (ePTFE). The medicine storage pool has three interfaces, one of which is used as a medicine liquid inlet, the other interface is used as a ventilation port, and the outlet is used for being connected with the micro pump. When the device is used for inner ear treatment, the outlet of a micro pump in the device is required to be connected with a drug delivery channel and the outlet of the channel is arranged above a round window membrane, and the generation rate of liquid drops is controlled by controlling the flow of the micro pump through an IC circuit so as to achieve the precision required by cochlear drug delivery, namely a liquid drop type working mode; when the device is used for intramuscular tissue injection, the outlet of the drug administration channel is required to be connected with the micro needle, the micro needle is used for direct injection, and the liquid medicine enters a human body through tissue permeation, namely a tissue permeation type working mode at the moment.
In this embodiment, the MEMS micro pump 2 is square, has a model of Bartels MP5, has a size of 14 × 3.5mm, is limited in the housing 1 to reduce the shaking and avoid damage, and the outlet of the MEMS micro pump 2 is connected to the outlet of the drug reservoir. The voltage of the lithium battery is amplified by the IC and then acts on the MEMS micropump to drive the MEMS micropump to transport liquid medicine, the working principle is that the voltage drives the diaphragm of the MEMS micropump 2 to vibrate up and down, and different voltages and frequencies correspond to different amplitudes and response frequencies of diaphragm vibration. The battery 4, the IC integrated circuit 3 and the MEMS micropump are connected by a lead.
As shown in fig. 2, fig. 2 is an overall structure of the control system of the present embodiment, and has a size of 4 × 5 × 1cm, which is similar to the shape of a hearing aid.
As shown in fig. 3 (a), in the droplet mode operation, the flow rate of the control system according to the present embodiment increases as the operating voltage increases. The minimum energy can reach 0.44ml/h fine flow rate (voltage 3v), the maximum flow rate can reach 36.16ml/h (voltage 25v), when the liquid medicine is transported in solid tissues, the flow rate is 0.77ml/h when the voltage is 10v due to certain resistance of physiological tissues, and the flow rate is 6.5ml/h when the voltage is 25v, which is only 0.18 times of that when the liquid medicine is unloaded. As shown in fig. 3 (b), the minimum fine flow rate of 1.1ml/h is achieved at a frequency of 5Hz, the maximum flow rate of 8.82ml/h is achieved at a frequency of 50Hz, and the flow rate increases and then decreases with the frequency response, and reaches a peak at 50 Hz.
In the tissue penetration mode of operation, the working flow rate was 0.84ml/h at a frequency of 10Hz and 3.55ml/h at a frequency of 50Hz, which is only 0.4 times that in the droplet mode.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.

Claims (5)

1.精准给药控制系统,其特征是:该控制系统包括集成在壳体的IC集成电路、MEMS微泵、储药池和储能装置;1. a precise drug delivery control system, characterized in that: the control system comprises an IC integrated circuit, a MEMS micropump, a drug storage tank and an energy storage device integrated in the housing; 所述IC集成电路分别与MEMS微泵和储能装置连接,所述MEMS微泵的入口与储药池的出口连接;The IC integrated circuit is respectively connected with the MEMS micro-pump and the energy storage device, and the inlet of the MEMS micro-pump is connected with the outlet of the medicine storage tank; 所述储药池还设置有入口和换气口;The medicine storage tank is also provided with an inlet and a ventilation port; 所述储能装置的电压经所述IC集成电路放大后作用于MEMS微泵,驱动微泵进行药液输入。The voltage of the energy storage device is amplified by the IC integrated circuit and then acts on the MEMS micro-pump to drive the micro-pump to input medicinal liquid. 2.根据权利要求1所述的精准给药控制系统,其特征在于:所述IC集成电路和储药池分别位于外壳体的上部和下部。2 . The precise drug delivery control system according to claim 1 , wherein the IC integrated circuit and the medicine storage tank are located at the upper and lower parts of the outer casing, respectively. 3 . 3.根据权利要求1所述的精准给药控制系统,其特征在于:所述储药池的材质为PE材料,储药池的换气口采用半透膜透气设计,所述半透膜材质为医用级ePTFE材料。3. The precise drug delivery control system according to claim 1, wherein: the material of the medicine storage tank is PE material, the ventilation port of the medicine storage tank adopts a semi-permeable membrane ventilation design, and the semi-permeable membrane material It is medical grade ePTFE material. 4.根据权利要求1所述的精准给药控制系统,其特征在于:所述MEMS微泵为方形。4 . The precise drug delivery control system according to claim 1 , wherein the MEMS micropump is square. 5 . 5.根据权利要求1所述的精准给药控制系统,其特征在于:所述储能装置为锂电池,所述锂电池放置在MEMS微泵上。5 . The precise drug delivery control system according to claim 1 , wherein the energy storage device is a lithium battery, and the lithium battery is placed on the MEMS micropump. 6 .
CN202111289039.6A 2021-11-02 2021-11-02 Precise dosing control system Pending CN113856014A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111289039.6A CN113856014A (en) 2021-11-02 2021-11-02 Precise dosing control system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111289039.6A CN113856014A (en) 2021-11-02 2021-11-02 Precise dosing control system

Publications (1)

Publication Number Publication Date
CN113856014A true CN113856014A (en) 2021-12-31

Family

ID=78986559

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111289039.6A Pending CN113856014A (en) 2021-11-02 2021-11-02 Precise dosing control system

Country Status (1)

Country Link
CN (1) CN113856014A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115430026A (en) * 2022-09-23 2022-12-06 南京鼓楼医院 Integrated artificial cochlea implant repeated delivery dosing electrode and control device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130053823A1 (en) * 2011-02-02 2013-02-28 Jason O. Fiering Drug Delivery Apparatus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130053823A1 (en) * 2011-02-02 2013-02-28 Jason O. Fiering Drug Delivery Apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115430026A (en) * 2022-09-23 2022-12-06 南京鼓楼医院 Integrated artificial cochlea implant repeated delivery dosing electrode and control device

Similar Documents

Publication Publication Date Title
KR100430703B1 (en) Corneal transplantation device for drug release
JP6038863B2 (en) MEMS device for delivery of therapeutic agents
Li et al. An electrochemical intraocular drug delivery device
CN113856014A (en) Precise dosing control system
US20200238062A1 (en) Trans middle ear-inner ear fluid flow implementations
US20160000602A1 (en) Mems device and method for delivery of therapeutic agents
Fateha Samad et al. Integrated microfluidic drug delivery devices: a component view
CN103751863B (en) Maxillary Cystic Disease Fenestration drainage negative pressure blocking device
CN216570461U (en) Dropping earplugs and medicinal liquid capsules combined with earplugs
CN217311313U (en) Disposable anti-reflux and anti-splash negative pressure drainage ball
CN221845612U (en) Negative pressure drainage wound dressing
CN108785789A (en) A kind of hydrocone type anti-blood back medical transfusion device
CN219185600U (en) Electroosmotic pump system
CN214762486U (en) An applicator with suction function
CN113262355B (en) Integrated piezoelectric driving intelligent insulin patch
CN202036633U (en) Novel venous transfusion device
CN211512920U (en) Multifunctional transfusion system
CN116943020A (en) A cochlear implant with sustainable quantitative drug delivery and its preparation method
RU43462U1 (en) TIP FOR IRRIGATION
KR20230147039A (en) wound care system
JP2012090879A (en) Negative pressure treatment apparatus and method for operating the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20211231

RJ01 Rejection of invention patent application after publication